Company page

Climb Bio, Inc.

Climb Bio, Inc. (ticker: CLYM) is a public company based in the United States with a market capitalization of approximately $655.7 million. The company focuses on innovative solutions in the biotechnology sector. Climb Bio is committed to advancing its research and development efforts to address unmet medical needs.

profileCLYM:NASDAQAI content: aiUpdated June 24, 2026/company/climb-bio-inc/c-foooje4j
Climb Bio, Inc. logo
Ticker
CLYM:NASDAQ
Asset type
Stock
Market cap
$655.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD